Apyx Medical Share Price (NASDAQ: APYX)

$2.17

▲

0.05

(2.36%)

Live

Last updated on August 15, 2025 at 10:40 PM IST

$₹

Check the interactive Apyx Medical Stock chart to analyse performance

Apyx Medical Corp Key Stats

Check Apyx Medical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.12
Open	$2.35
Market Capitalization	$88.9M
Today's Volume	$146.3K
Revenue TTM	$46.5M
EBITDA	$-11.8M
Earnings Per Share (EPS)	$-0.44
Profit Margin	-37.11%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-154.54%

Stock Returns calculator for Apyx Medical Stock including INR - Dollar returns

The Apyx Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Apyx Medical investment value today

Current value as on today

₹1,61,502

Returns

₹61,502

(+61.5%)

Returns from Apyx Medical Stock

₹57,246 (+57.25%)

Dollar Returns*

₹4,255 (+4.26%)

Indian investors sentiment towards Apyx Medical Stock

27%

Period: Jul 15, 2025 to Aug 14, 2025. Change in 30 Days versus previous period

Search interest for Apyx Medical Stock from India on INDmoney has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Apyx Medical Corp

Name
Holdings %
Name
Holdings %
Archon Capital Management LLC
8.72%
Nantahala Capital Management, LLC
8.62%
Royce & Associates, LP
6.68%
Vanguard Group Inc
3.90%
Silverberg Bernstein Capital Management LLC
1.71%
Horizon Asset Management Inc/ny
1.63%

Analyst Recommendation on Apyx Medical Stock

Rating

Trend

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Apyx Medical(by analysts ranked 0 to 5 stars)

Apyx Medical Share Price Target

What analysts predicted

Upside of 84.33%

Target:

$4.00

Current:

$2.17

Apyx Medical share price target is $4.00, a slight Upside of 84.33% compared to current price of $2.17 as per analysts' prediction.

Apyx Medical Stock Insights

Price Movement
In the last 3 months, APYX stock has moved up by 45.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 9.43M → 11.37M (in $), with an average increase of 17.1% per quarter
Increasing Net Profit
Netprofit is up for the last 7 quarters, -9.60M → -3.77M (in $), with an average increase of 17.5% per quarter
APYX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 147.1% return, outperforming this stock by 218.3%

Apyx Medical Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$28.2M	↑ 68.73%
Net Income	$-19.7M	↓ 130.7%
Net Profit Margin	-69.79%	↓ 453.4%

	FY20	Y/Y Change
Revenue	$27.7M	↓ 1.57%
Net Income	$-11.9M	↓ 39.41%
Net Profit Margin	-42.96%	↑ 26.83%

	FY21	Y/Y Change
Revenue	$48.5M	↑ 75.08%
Net Income	$-15.2M	↑ 27.67%
Net Profit Margin	-31.33%	↑ 11.63%

	FY22	Y/Y Change
Revenue	$44.5M	↓ 8.26%
Net Income	$-23.3M	↑ 53.14%
Net Profit Margin	-52.3%	↓ 20.97%

	FY23	Y/Y Change
Revenue	$52.3M	↑ 17.61%
Net Income	$-18.7M	↓ 19.61%
Net Profit Margin	-35.75%	↑ 16.55%

	FY24	Y/Y Change
Revenue	$48.1M	↓ 8.11%
Net Income	$-23.5M	↑ 25.38%
Net Profit Margin	-48.78%	↓ 13.03%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$14.5M	↓ 0.84%
Net Income	$-7.6M	↓ 21.14%
Net Profit Margin	-52.11%	↑ 13.41%

	Q2 FY24	Q/Q Change
Revenue	$12.1M	↓ 16.44%
Net Income	$-6.6M	↓ 13.46%
Net Profit Margin	-53.96%	↓ 1.85%

	Q3 FY24	Q/Q Change
Revenue	$11.5M	↓ 5.45%
Net Income	$-4.7M	↓ 28.26%
Net Profit Margin	-40.94%	↑ 13.02%

	Q4 FY24	Q/Q Change
Revenue	$14.2M	↑ 23.81%
Net Income	$-4.6M	↓ 1.59%
Net Profit Margin	-32.54%	↑ 8.4%

	Q1 FY25	Q/Q Change
Revenue	$9.4M	↓ 33.69%
Net Income	$-4.2M	↓ 10.33%
Net Profit Margin	-44.01%	↓ 11.47%

	Q2 FY25	Q/Q Change
Revenue	$11.4M	↑ 20.6%
Net Income	$-3.8M	↓ 8.96%
Net Profit Margin	-33.22%	↑ 10.79%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$19.1M	↑ 77.22%

	FY20	Y/Y Change
Profit	$17.5M	↓ 8.49%

	FY21	Y/Y Change
Profit	$33.6M	↑ 91.96%

	FY22	Y/Y Change
Profit	$29.1M	↓ 13.3%

	FY23	Y/Y Change
Profit	$33.8M	↑ 15.89%

	FY24	Y/Y Change
Profit	$29.4M	↓ 13.03%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$5.9M	↑ 46.45%

	Q2 FY24	Q/Q Change
Profit	$2.8M	↓ 52.75%

	Q3 FY24	Q/Q Change
Profit	$7.0M	↑ 147.39%

	Q4 FY24	Q/Q Change
Profit	$9.0M	↑ 28.9%

	Q1 FY25	Q/Q Change
Profit	$5.7M	↓ 36.8%

	Q2 FY25	Q/Q Change
Profit	$7.1M	↑ 25.03%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-18.5M	↓ 12.07%
Investing Cash Flow	$60.5M	↑ 106.62%
Financing Cash Flow	$147.0K	↓ 105.9%

	FY20	Y/Y Change
Operating Cash Flow	$-16.1M	↓ 13.04%
Investing Cash Flow	$-581.0K	↓ 100.96%
Financing Cash Flow	$-73.0K	↓ 149.66%

	FY21	Y/Y Change
Operating Cash Flow	$-10.4M	↓ 34.96%
Investing Cash Flow	$-723.0K	↑ 24.44%
Financing Cash Flow	$24.0K	↓ 132.88%

	FY22	Y/Y Change
Operating Cash Flow	$-20.3M	↑ 94.09%
Investing Cash Flow	$-1.0M	↑ 39.7%
Financing Cash Flow	$217.0K	↑ 804.17%

	FY23	Y/Y Change
Operating Cash Flow	$-5.2M	↓ 74.12%
Investing Cash Flow	$6.7M	↓ 766.73%
Financing Cash Flow	$32.2M	↑ 14723.04%

	FY24	Y/Y Change
Operating Cash Flow	$-18.0M	↑ 243.82%
Investing Cash Flow	$-722.0K	↓ 110.72%
Financing Cash Flow	$6.7M	↓ 79.03%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-6.3M	↑ 1284.5%
Investing Cash Flow	$-35.0K	↓ 62.37%
Financing Cash Flow	$-5.0K	↓ 100.02%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-4.3M	↓ 31.73%
Investing Cash Flow	$-289.0K	↑ 725.71%
Financing Cash Flow	$-5.0K	↑ 0.0%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-4.4M	↑ 2.56%
Investing Cash Flow	$-153.0K	↓ 47.06%
Financing Cash Flow	$-5.0K	↑ 0.0%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-2.9M	↓ 33.85%
Investing Cash Flow	$-245.0K	↑ 60.13%
Financing Cash Flow	$6.8M	↓ 135300.0%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-702.0K	↓ 76.1%
Investing Cash Flow	$-55.0K	↓ 77.55%
Financing Cash Flow	$25.0K	↓ 99.63%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-1.2M	↑ 75.64%
Investing Cash Flow	$-265.0K	↑ 381.82%
Financing Cash Flow	$25.0K	↑ 0.0%

Apyx Medical Technicals Summary

Sell

Neutral

Buy

Apyx Medical is currently in a neutral trading position according to technical analysis indicators.

Apyx Medical Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Apyx Medical Corp	2.87%	43.33%	55.8%	-70.26%	-57.51%
Medtronic Plc	2.49%	-0.85%	10.01%	-3.45%	-9.66%
Edwards Lifesciences Corp.	2.71%	2.64%	14.8%	-23.54%	-0.3%
Boston Scientific Corp.	0.95%	-1.83%	34.27%	145.97%	164.73%
Stryker Corporation	-3.14%	-1.71%	13.29%	68.89%	100.28%
Abbott Laboratories	-1.82%	-0.97%	16.59%	15.45%	28.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Apyx Medical Corp	NA	NA	NA	-0.34	-1.55	-0.12	NA	0.19
Medtronic Plc	25.51	25.51	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	32.71	32.71	4.64	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	61.01	61.01	1.78	2.98	0.12	0.05	NA	15.14
Stryker Corporation	50.26	50.26	2.16	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.24	16.24	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Apyx Medical Corp	Buy	$88.9M	-57.51%	NA	-37.11%
Medtronic Plc	Buy	$118.0B	-9.66%	25.51	13.9%
Edwards Lifesciences Corp.	Buy	$45.9B	-0.3%	32.71	72.96%
Boston Scientific Corp.	Buy	$151.9B	164.73%	61.01	13.55%
Stryker Corporation	Buy	$144.9B	100.28%	50.26	12.25%
Abbott Laboratories	Buy	$225.2B	28.43%	16.24	32.43%

About Apyx Medical Corp

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Organization	Apyx Medical
Employees	220
CEO	Mr. Charles D. Goodwin II
Industry	Health Technology

Key Management of Apyx Medical Corp

Name	Title
Mr. Stavros George Vizirgianakis B.Com.	Executive Chairman
Mr. Charles D. Goodwin II	President, CEO & Director
Mr. Matthew C. Hill CPA	CFO, Treasurer & Secretary
Mr. Shawn D. Roman	Chief Operating Officer
Mr. Moshe Citronowicz	Senior Vice President
Ms. Dolores Catania	Chief of Confidence

Important FAQs about investing in APYX Stock from India :

What is Apyx Medical share price today?

Apyx Medical share price today is $2.17 as on August 15, 2025 at 10:40 PM IST. Apyx Medical share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Apyx Medical share?

Apyx Medical share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Apyx Medical stock price today, August 15, 2025 at 10:40 PM IST is trending at $2.17, lower by 20.51% versus the 52 week high.

How to invest in Apyx Medical Stock (APYX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Apyx Medical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apyx Medical Shares that will get you 0.6912 shares as per Apyx Medical share price of $2.17 per share as on August 15, 2025 at 10:40 PM IST.

What is the minimum amount required to buy Apyx Medical Stock (APYX) from India?

Indian investors can start investing in Apyx Medical (APYX) shares with as little as ₹87.492 or $1 (as of August 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Apyx Medical stock (as per the Rupee-Dollar exchange rate as on August 15, 2025). Based on Apyx Medical share’s latest price of $2.17 as on August 15, 2025 at 10:40 PM IST, you will get 4.6083 shares of Apyx Medical. Learn more about fractional shares .

What are the returns that Apyx Medical has given to Indian investors in the last 5 years?

Apyx Medical stock has given -57.51% share price returns and 16.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?